Elliott Derick A. 4

What Happened Derick A. Elliott, Executive Vice President, Commercial at Outset Medical (OM), was granted 96,000 restricted stock units (RSUs) on April 6, 2026. The grant was reported as an award/acquisition (Code A) with an acquisition price of $0 (typical for RSU compensation). These RSUs are contingent rights to receive one share of common stock per RSU upon vesting.

Key Details

• Transaction date and type: 2026-04-06 — Grant/Award of 96,000 RSUs (Code A); reported acquisition price $0.
• Vesting: 33.33% vest on April 6, 2027; remaining 66.66% vest in equal quarterly installments over the following two years (Feb 15, May 15, Aug 15, Nov 15), subject to continuous service.
• Shares owned after transaction: Not specified in the provided filing.
• Filing timeliness: Reported on Apr 8, 2026 (two days after the grant), consistent with standard Form 4 timing requirements.
• Footnote: Each RSU represents a contingent right to one share upon vesting; no immediate cash or shares issued at grant.

Context RSU grants are a common form of executive compensation and retention incentive. This award does not involve an open-market purchase or sale and does not represent an immediate change in circulating shares until units vest and are settled. Such grants are routine and should be viewed as compensation rather than a direct market sentiment signal.